Biopharmaceutical Commercialization

The concentration in Biopharmaceutical Commercialization is designed to provide students with the knowledge and skills necessary to build a rewarding career in the biopharma industry while focusing on the commercialization of advanced medicines, including cell and gene therapies, recombinant vaccines and monoclonal antibodies. Additionally, students will gain an understanding of the production of biopharmaceuticals and biologics, their regulatory and quality-based requirements, and key commercialization strategies and analytics.

Through collaboration with the Jefferson Institute for Bioprocessing (JIB) to create this unique opportunity, students within the School of Business can now gain valuable insight and training from industry experts and therefore gain highly marketable skills in preparation to enter a growing international industry. The courses are scheduled to meet the needs of working professionals and can be taken at either the JIB Single-Use Pilot Plant facility or in online formats.

Unique Aspects

• Participants completing this 9-credit concentration will be prepared to engage in high level discussions and business-related decision-making processes across all functional areas of the biopharma industries.
• The concentration is designed to create the opportunity for participants with no prior knowledge of the industry to gain employment in areas such as supply chain management, portfolio management, project management, marketing, legal, sales and related areas.
• The concentration will provide participants with the knowledge, background and ability to navigate and contribute to all commercial aspects of the biopharmaceutical industry, with an emphasis on next generation therapies including cell and gene therapy, and advanced vaccines.
• Required coursework offered in both online and live / hybrid formats.

By the end of the concentration the participants will be able to:

• Describe the growth and importance of the biopharma industry
• Explain the drivers and growth of major biologics for the next decade and beyond
• Describe the impact of biologics on the global and US job markets and economies
• Describe current and future trends in biologics
• Explain cost and pricing strategies for biologics
• Explain the role of innovation in biopharma and its impact on the future growth of next generation therapies
• Explain the job responsibilities and roles in different functional areas in biomanufacturing
• Identify and predict workforce challenges in bioprocessing, biomanufacturing, and cell/gene therapy
• Speak to solutions through training and education on how to address workforce challenges
• Illustrate an understanding of career paths in biopharma and cell/gene therapy

• ENGR 621 Introduction to Biopharmaceuticals and Biologics Production
• ENGR 619 Biopharmaceuticals and Biologics: Regulatory and Quality
• ENGR 620 Biopharmaceutical Commercialization: Strategy and Analytics

Total Credits: 9